Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-12-01
2009-12-29
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07638552
ABSTRACT:
The invention relates to a method of increasing the bioavailability of glycopyrrolate by administration of a therapeutically effective amount of glycopyrrolate without food. The invention also provides a kit comprising a pharmaceutical composition comprising a therapeutically effective amount of glycopyrrolate and a pharmaceutically acceptable carrier, prescribing information including advice regarding the administration of glycopyrrolate without food to improve bioavailability, and a container.
REFERENCES:
patent: 4600708 (1986-07-01), Reuter et al.
patent: 6063808 (2000-05-01), Fabiano et al.
patent: 6204285 (2001-03-01), Fabiano et al.
patent: 6407128 (2002-06-01), Scaife et al.
patent: 6433003 (2002-08-01), Bobrove et al.
patent: 6455557 (2002-09-01), Pellegrini et al.
patent: 2 019 180 (1994-09-01), None
patent: WO 01/08681 (2001-02-01), None
Radus et al., Journal Pharmaceutical Sci., (Mar. 1983), 72(3), pp. 221-224 (abstract).
Charman et al.,J. Pharm. Sci., 86(3): 269-282(1997).
Kirk et al.,Am. Fam. Physician, 51(5): 1175-1182 (1995).
Mier et al.,Arch. Pediatr. Adolesc. Med., 154: 1214-1218 (2000).
Toothaker et al.,Ann. Rev. Pharmacol. Toxicol., 20:173-199 (1980).
Welling,Clinical Pharmacokinetics, 9: 404-434 (1984).
Winstanley et al.,Br. J. Clin. Pharmac., 28: 621-628 (1989).
Ali-Melkkilä et al.,Acta Anaesthesiol Scand, 33, 513-517 (1989).
Ali-Melkkilä et al.,Acta Anaesthesiol Scand, 37, 633-642 (1993).
Chen, Connie,Am. J. Health-Syst Pharm, 55, 905-025 (May 1, 1998).
Evans, Allan M.,Therapeutic Drug Monitoring, 22, 131-136 (2000).
Gillen et al.,Best Pract Res Clin Gastroenterol, 15 (3), 487-495 (Jun. 2001).
Greene et al.,Clin. Pharmacokinet, 33(4), 260-275 (Oct. 1997).
Loi et al.,Clin. Pharmacokinet, 37 (2), 91-104 (Aug. 1999).
Martinez et al.,J. Clin. Pharmacol, 42, 620-643 (2002).
Pelkonen et al.,Eur. J. Clin. Pharmacol., 57, 621-629 (2001).
Rautakorpi et al.,Pharmacology&Toxicology, 83, 132-134 (1998).
Rautakorpi et al.,J. Clin. Anesth., 6, 217-220 (May/Jun. 1994).
Singh, Brahma N.,Clin. Pharmacokinet, 37 (3), 213-255 (Sep. 1999).
Temple et al.,Annals Pharmacotherapy, 33, 1203-1210 (Nov. 1999).
Van Leerdam et al.,Best Prac Res Clin Gastroenterol, 15 (3), 463-475 (2001).
Walter-Sack et al.,Clin. Pharmacokinet, 31(1), 47-64 (Jul. 1996).
Roberts Alan
Venkataraman Balaji
Leydig , Voit & Mayer, Ltd.
Sciele Pharma, Inc.
Spivack Phyllis G.
LandOfFree
Method for increasing the bioavailability of glycopyrrolate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for increasing the bioavailability of glycopyrrolate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for increasing the bioavailability of glycopyrrolate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4080135